SCHEMBL9300933

SCHEMBL9300933

COC(=O)c1cccc2c(O)cccc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.66
TSHR P16473 1/20 0.66
CA1 P00915 4/20 0.59
CA2 P00918 4/20 0.59
CA9 Q16790 4/20 0.59
CA12 O43570 3/20 0.59
CA7 P43166 3/20 0.59
CA14 Q9ULX7 3/20 0.59
ESR1 P03372 4/20 0.55
ESR2 Q92731 4/20 0.55
KDM4E B2RXH2 2/20 0.53
KMT2A Q03164 2/20 0.51
MEN1 O00255 1/20 0.51
CDC25B P30305 2/20 0.50
ALDH1A1 P00352 1/20 0.48
CFTR P13569 1/20 0.48
HSD17B10 Q99714 1/20 0.48
POLB P06746 2/20 0.47
GAA P10253 1/20 0.47
BRD4 O60885 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL70429 0.90 LMNA (0.59) LMNATSHRCA1CA2CA9
SCHEMBL2174563 0.89 KDM4E (0.61) LMNATSHRCA1CA2CA9
SCHEMBL3230050 0.82 NR4A2 (0.53) LMNATSHRKDM4ECDC25BALDH1A1
SCHEMBL13441744 0.82 KMT2A (0.53) LMNATSHRCA1CA2CA9
SCHEMBL6953102 0.82 LMNA (0.58) LMNATSHRCA1CA2CA9
SCHEMBL70381 0.81 BRD4 (0.59) LMNATSHRCA1CA2CA9
SCHEMBL29434198 0.81 BRD4 (0.59) LMNATSHRCA1CA2CA9
SCHEMBL2748381 0.81 LMNA (0.51) LMNATSHRCA1CA2CA9
SCHEMBL23909537 0.81 LMNA (0.50) LMNATSHRCA1CA2CA9
SCHEMBL3207564 0.81 NR4A2 (0.58) LMNATSHRCA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4448869-A HYDROXY AND CARBOXY OR ACYL SUBSTITUTED BENZENE OR NAPHTHALENE FUJI PHOTO FILM CO., LTD. (JP) 1984-05-15 US claimed
EP-4543858-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES Draupnir Bio ApS (DK) 2025-04-30 EP disclosed
WO-2023247754-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES DRAUPNIR BIO APS (DK) 2023-12-28 WO disclosed
US-20100075945-A1 GRAM-POSITIVE CARBAPENEM ANTIBACTERIALS AND PROCESSES FOR THEIR PREPARATION CHOI WOO-BAEG 2010-03-25 US disclosed
US-20100075945-A1 GRAM-POSITIVE CARBAPENEM ANTIBACTERIALS AND PROCESSES FOR THEIR PREPARATION CHOI WOO-BAEG 2010-03-25 US disclosed
US-7632828-B2 Gram-positive carbapenem antibacterials and processes for their preparation FOB SYNTHESIS, INC. (US) 2009-12-15 US disclosed
US-7632828-B2 Gram-positive carbapenem antibacterials and processes for their preparation FOB SYNTHESIS, INC. (US) 2009-12-15 US disclosed
CN-100393700-C Cathepsin cysteine protease inhibitors MERCK FROSST CANADA INC (CA) 2008-06-11 CN disclosed
CN-1812967-A Cathepsin cysteine protease inhibitors MERCK FROSST CANADA INC (CA) 2006-08-02 CN disclosed
US-5298593-A Polymerization of ester monomer, aromatic dicarboxylic acid, and oxyaromatic carboxylic acid MITSUBISHI PETROCHEMICAL COMPANY, LTD. (JP) 1994-03-29 US disclosed
EP-0520428-A2 Method of producing thermotropic liquid crystalline polyester MITSUBISHI CHEMICAL CORPORATION (JP) 1992-12-30 EP disclosed
US-4448869-A HYDROXY AND CARBOXY OR ACYL SUBSTITUTED BENZENE OR NAPHTHALENE FUJI PHOTO FILM CO., LTD. (JP) 1984-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075945-A1 GRAM-POSITIVE CARBAPENEM ANTIBACTERIALS AND PROCESSES FOR THEIR PREPARATION MGAM, GSK3B, GSK3A LMNA 1346/4885TSHR 4841/4885CA1 3339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.